Hemoglobin glutamer-250 (bovine)

DB19235InvestigationalProtein Based Therapies

Hemoglobin glutamer-250 (bovine) is under investigation in clinical trial NCT00300040 (Safety/feasibility Study of HBOC-201 in Amputation At/below Knee From Critical Lower Limb Ischemia).

Also known as: Hemoglobin-based oxygen carrier 201 is purified, glutaraldehyde-polymerized, bovine hemoglobin, mw 250000 · Hemopure
Code names: HBOC-201

Resolves to

Compound

UNII1XQE66T19HCAS192230-36-7

What you can answer from here — as of September 26, 2026

1Protein targetEach mapped to UniProt, with action and pharmacological action

Listed above

8Clinical trialsPhase, status and sponsor resolved per trial

1+ReferenceStructured and connected to the statements they support

Which companies are running trials of Hemoglobin glutamer-250 (bovine), in which indications and phases, and which of those programs are still active?

Answer this in Biopharma OS Sign in to your account

Create a free account or log in to explore the full data card.

Create Account